VitaNova Life Sciences (VNOV) Share-based Compensation (2024 - 2025)

VitaNova Life Sciences (VNOV) reported Share-based Compensation of $500.0 for Q1 2025, down 33.33% quarter-over-quarter from $750.0 in Q4 2024.

VitaNova Life Sciences (VNOV) Share-based Compensation (2024 - 2025) Analysis & Trends

VitaNova Life Sciences has reported Share-based Compensation for 2 years, with the latest figure at $500.0 in Q1 2025.

For the quarter ending Q1 2025, Share-based Compensation changed N/A year-over-year to $500.0; the trailing twelve-month figure through Oct 2025 stood at $500.0 (down 80.0% YoY), and the FY2025 full-year result was $2000.0, up 100.0% from the prior year.
Share-based Compensation for Q1 2025 stood at $500.0, down from $750.0 in the prior quarter.
The five-year high for Share-based Compensation was $1000.0 in Q2 2024, with the low at $500.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Share-based Compensation (Qtr)
1	Akso Health	2,315,158.81 Bn	2,315,158.63 Bn	-	-
2	Mckesson	92.76 Bn	89.18 Bn	4.04 Bn	-
3	Cencora	52.82 Bn	50.83 Bn	3.59 Bn	28.00 Mn
4	Cardinal Health	52.17 Bn	48.39 Bn	2.50 Bn	129.00 Mn
5	Henry Schein	9.19 Bn	9.71 Bn	1.07 Bn	3.00 Mn
6	Accendra Health	246.88 Mn	-90.00 Mn	312.39 Mn	3.09 Mn
7	Edap Tms	161.92 Mn	146.92 Mn	8.15 Mn	302,000.00
8	111	107.47 Mn	25.61 Mn	23.58 Mn	-
9	Cosmos Health	9.42 Mn	7.26 Mn	1.38 Mn	535,786.00
10	VitaNova Life Sciences	-	-	316,343.00	-

Download Data